Polycystic ovary syndrome and fat distribution: The central issue?

References

• Agus MS, Swain JF, Larson CL, et al. Dietary composition and physiologic adaptations to energy restriction. American Journal of Clinical Nutrition 2000; 71: 901–907
   PubMed Web of Science ®Google Scholar
• Andersson B. Hyperandrogenicity in women. Clinical Laboratory 1999; 45: 165–176
   Google Scholar
• Ashton WD, Nanchahal K, Wood DA. Body mass index and metabolic risk factors for coronary heart disease in women. European Heart Journal 2001; 22: 46–55
   PubMed Web of Science ®Google Scholar
• Azziz R, Ehrmann D, Legro RS, et al. Troglitazone improves ovulation and hirsutism in the polycystic ovary syndrome: a multicenter, double blind, placebo-controlled trial. Journal of Clinical Endocrinology and Metabolism 2001; 86: 1626–1632
   PubMed Web of Science ®Google Scholar
• Barzilai N, She L, Liu BQ, et al. Surgical removal of visceral fat reverses hepatic insulin resistance. Diabetes 1999; 48: 94–98
   PubMed Web of Science ®Google Scholar
• Bengtsson C, Bjorkelund C, Lapidus L, et al. Associations of serum lipid concentrations and obesity with mortality in women: 20 year follow up of participants in prospective population study in Gothenburg, Sweden [see comments]. British Medical Journal 1993; 307: 1385–1388
   PubMedGoogle Scholar
• Bjorntorp P. Hormonal control of regional fat distribution. Human Reproduction 1997; 12(Supplement 1)21–25
   PubMedGoogle Scholar
• Boyko EJ, Leonetti DL, Bergstrom RW, et al. Low insulin secretion and high fasting insulin and C-peptide levels predict increased visceral adiposity 5-year follow-up among initially nondiabetic Japanese-American men. Diabetes 1996; 45: 1010–1015
   PubMed Web of Science ®Google Scholar
• Boyko EJ, Fujimoto WY, Leonetti DL, et al. Visceral adiposity and risk of type 2 diabetes: a prospective study among Japanese Americans. Diabetes Care 2000; 23: 465–471
   PubMed Web of Science ®Google Scholar
• Clark AM, Ledger W, Galletly C, et al. Weight loss results in significant improvement in pregnancy and ovulation rates in anovulatory obese women. Human Reproduction 1995; 10: 2705–2712
   PubMed Web of Science ®Google Scholar
• Clark AM, Thornley B, Tomlinson L, et al. Weight loss in obese infertile women results in improvement in reproductive outcome for all forms of fertility treatment. Human Reproduction 1998; 13: 1502–1505
   PubMed Web of Science ®Google Scholar
• Despres JP. Dyslipidaemia and obesity. Balliere's Clinical Endocrinology and Metabolism 1994; 8: 629–660
   PubMed Web of Science ®Google Scholar
• Despres JP, Lemieux I, Prud'homme D. Treatment of obesity: need to focus on high risk abdominally obese patients. British Medical Journal 2001; 322: 716–720
   PubMed Web of Science ®Google Scholar
• Dunaif A. Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis. Endocrine Reviews 1997; 18: 774–800
   PubMed Web of Science ®Google Scholar
• Dunaif A, Scott D, Finegood D, et al. The insulin-sensitizing agent troglitazone improves metabolic and reproductive abnormalities in the polycystic ovary syndrome. Journal of Clinical Endocrinology and Metabolism 1996; 81: 3299–3306
   PubMed Web of Science ®Google Scholar
• Galtier D, Pujol P, Dewailly D, et al. Choice of stimulation in polycystic ovarian syndrome: the influence of obesity. Human Reproduction 1997; 12(Supplement 1)88–96
   Google Scholar
• Goodpaster BH, Kelley DE, Wing RR, et al. Effects of weight loss on regional fat distribution and insulin sensitivity in obesity. Diabetes 1999; 48: 839–847
   PubMed Web of Science ®Google Scholar
• Hoeger K. Obesity and weight loss in polycystic ovary syndrome. Obstetrics and Gynecology Clinics of North America 2001; 28: 85–97
   PubMed Web of Science ®Google Scholar
• Holte J, Bergh T, Gennarelli G, et al. The independent effects of polycystic ovary syndrome and obesity on serum concentrations of gonadotrophins and sex steroids in premenopausal women. Clinical Endocrinology 1994a; 41: 473–481
   PubMed Web of Science ®Google Scholar
• Holte J, Bergh T, Berne C, et al. Enhanced early insulin response to glucose in relation to insulin resistance in women with polycystic ovary syndrome and normal glucose tolerance. Journal of Clinical Endocrinology and Metabolism 1994b; 78: 1052–1058
   PubMed Web of Science ®Google Scholar
• Holte J, Bergh T, Berne C, et al. Restored insulin sensitivity but persistently increased early insulin secretion after weight loss in obese women with polycystic ovary syndrome. Journal of Clinical Endocrinology and Metabolism 1995; 80: 2586–2593
   PubMed Web of Science ®Google Scholar
• Hopkinson ZE, Sattar N, Fleming R, et al. Polycystic ovarian syndrome: the metabolic syndrome comes to gynaecology. British Medical Journal 1998; 317: 329–332
   PubMed Web of Science ®Google Scholar
• Jaatinen TA, Anttila L, Erkkola R, et al. Hormonal responses to physical exercise in patients with polycystic ovarian syndrome. Fertility and Sterility 1993; 60: 262–267
   PubMed Web of Science ®Google Scholar
• Kiddy DS, Hamilton F, Bush A, et al. Improvement in endocrine and ovarian function during dietary treatment of obese women with polycystic ovary syndrome. Clinical Endocrinology 1992; 36: 105–111
   PubMed Web of Science ®Google Scholar
• Kirchengast S, Huber J. Body composition characteristics and body fat distribution in lean women with polycystic ovary syndrome. Human Reproduction 2001; 16: 1255–1260
   PubMed Web of Science ®Google Scholar
• Larson DE, Hunter GR, Williams MJ, et al. Dietary fat in relation to body fat and intraabdominal adipose tissue: a cross-sectional analysis. American Journal of Clinical Nutrition 1996; 64: 677–684
   PubMed Web of Science ®Google Scholar
• Lean ME, Han TS, Morrison CE. Waist circumference as a measure for indicating need for weight management. British Medical Journal 1995; 311: 158–161
   PubMed Web of Science ®Google Scholar
• Lefebvre P, Bringer J, Renard E, et al. Influences of weight, body fat patterning and nutrition on the management of PCOS. Human Reproduction 1997; 12(Supplement 1)72–81
   PubMedGoogle Scholar
• Legro RS. The genetics of obesity: lessons for polycystic ovary syndrome. Annals of the New York Academy of Sciences 2000; 900: 193–202
   PubMed Web of Science ®Google Scholar
• Legro RS, Finegood D, Dunaif A. A fasting glucose to insulin ratio is a useful measure of insulin sensitivity in women with polycystic ovary syndrome. Journal of Clinical Endocrinology and Metabolism 1998; 83: 2694–2698
   PubMed Web of Science ®Google Scholar
• Lemieux S, Prud'homme D, Nadeau A, et al. Seven-year changes in body fat and visceral adipose tissue in women: association with indexes of plasma glucose-insulin homeostasis. Diabetes Care 1996; 19: 983–991
   PubMed Web of Science ®Google Scholar
• Lord J, Thomas R, Fox B, et al. Polycystic ovary syndrome — the relationship between insulin resistance, obesity and visceral fat mass. Human Fertility 2001; 4: 194–194, (Abstract O18)
   Google Scholar
• McLaughlin T, Abbasi F, Carantoni M, et al. Differences in insulin resistance do not predict weight loss in response to hypocaloric diets in healthy obese women. Journal of Clinical Endocrinology and Metabolism 1999; 84: 578–581
   PubMed Web of Science ®Google Scholar
• Matsuzawa Y, Shimomura I, Nakamura T, et al. Pathophysiology and pathogenesis of visceral fat obesity. Obesity Research 1995; 3(Supplement 2)187S–194S
   Google Scholar
• Moghetti P, Castello R, Negri C, et al. Metformin effects on clinical features, endocrine and metabolic profiles, and insulin sensitivity in polycystic ovary syndrome: a randomized, double-blind, placebo-controlled 6-month trial, followed by open, long-term clinical evaluation. Journal of Clinical Endocrinology and Metabolism 2000; 85: 139–146
   PubMed Web of Science ®Google Scholar
• Nestler JE. Insulin regulation of human ovarian androgens. Human Reproduction 1997; 12(Supplement 1)53–62
   PubMedGoogle Scholar
• Nestler JE. Insulin resistance and the polycystic ovary syndrome: recent advances. Current Opinion in Endocrinology and Diabetes 2000; 7: 345–349
   Google Scholar
• Peiris An, Sothmann MS, Hoffmann RG, et al. Adiposity, fat distribution, and cardiovascular risk. Annals of Internal Medicine 1989; 110: 867–872
   PubMed Web of Science ®Google Scholar
• Pouliot MC, Despres JP, Lemieux S, et al. Waist circumference and abdominal sagittal diameter: best simple anthropometric indexes of abdominal visceral adipose tissue accumulation and related cardiovascular risk in men and women. American Journal of Cardiology 1994; 73: 460–468
   PubMed Web of Science ®Google Scholar
• Reaven G. Syndrome X: 10 years after. Drugs 1999; 58(Supplement 1)19–82
   PubMedGoogle Scholar
• Rebuffe S, Cullberg G, Lundberg PA, et al. Anthropometric variables and metabolism in polycystic ovarian disease. Hormone and Metabolic Research 1989; 21: 391–397
   PubMed Web of Science ®Google Scholar
• Ruderman N, Chisholm D, Pi-Sunyer X, et al. The metabolically obese, normal-weight individual revisited. Diabetes 1998; 47: 699–713
   PubMed Web of Science ®Google Scholar
• Samaras A, Campbell LV. Increasing incidence of type 2 diabetes in the third millennium: is abdominal fat the central issue?. Diabetes Care 2000; 23: 441–442
   PubMed Web of Science ®Google Scholar
• Samaras K, Kelly PJ, Chiano MN, et al. Genes versus environment: the relationship between dietary fat and total and central abdominal fat. Diabetes Care 1998; 21: 2069–2076
   PubMed Web of Science ®Google Scholar
• Samaras K, Kelly PJ, Chiano MN, et al. Genetic and environmental influences on total-body and central abdominal fat: the effect of physical activity in female twins. Annals of Internal Medicine 1999; 130: 873–882
   PubMed Web of Science ®Google Scholar
• Slabber M, Barnard HC, Kuyl JM, et al. Effects of a low-insulin-response, energy-restricted diet on weight loss and plasma insulin concentrations in hyperinsulinemic obese females. American Journal of Clinical Nutrition 1994; 60: 48–53
   PubMed Web of Science ®Google Scholar
• Tuomilehto J, Lindstrom J, Eriksson JG, et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. New England Journal of Medicine 2001; 344: 1343–1350
   PubMed Web of Science ®Google Scholar
• van der Kooy K, Leenen R, Seidell JC, et al. Waist-hip ratio is a poor predictor of changes in visceral fat. American Journal of Clinical Nutrition 1993; 57: 327–333
   PubMed Web of Science ®Google Scholar
• Vandermolen DT, Ratts VS, Evans WS, et al. Metformin increases the ovulatory rate and pregnancy rate from clomiphene citrate in patients with polycystic ovary syndrome who are resistant to clomiphene citrate alone. Fertility and Sterility 2001; 75: 310–315
   PubMed Web of Science ®Google Scholar
• Wilkin TJ, Choquet RC, Schmouker Y, et al. Maximum calorie (subthreshold) dieting of the obese and its hormonal response. Acta Endocrinologica 1983; 103: 184–187
   PubMedGoogle Scholar
• Williams KV, Korytkowski MT. Syndrome X: pathogenesis, clinical and therapeutic aspects. Diabetes Nutrition and Metabolism Clinical and Experimental 1998; 11: 140–152
   Web of Science ®Google Scholar
• Yamashita S, Nakamura T, Shimomura I, et al. Insulin resistance and body fat distribution: contribution of visceral fat accumulation to the development of insulin resistance and atherosclerosis. Diabetes Care 1996; 19: 287–291
   PubMed Web of Science ®Google Scholar